Cluster 302: treated previously patients ixazomib therapy eligible prior subjects study chemotherapy 
Cluster 370: bevacizumab prior treatment patients therapy received weeks treated previously regimen 
Cluster 1655: ibrutinib prior treatment therapy btk exposure investigational inhibitors previously patients 
Cluster 2127: avastin bevacizumab received prior weeks treatment therapy use scheduled planned 
